Option Care Health Q3 revenue slightly beats estimates

Overview

• US infusion services provider's Q3 revenue rose 4.1%, slightly beating analyst expectations

• Q3 adjusted EBITDA beat analyst expectations

Outlook

• Option Care Health has withdrawn its previously disclosed financial guidance due to pending acquisition

Result Drivers

• REVENUE GROWTH - Q3 revenue increased 4.1% year-over-year

• COSTS AND EXPENSES - Operating costs and expenses rose modestly, with higher selling, general and administrative expenses and increased restructuring and integration costs

Company press release:

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 11 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for Option Care Health Inc is $32.00, about 0.7% above its November 3 closing price of $31.77

• The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 12 three months ago

Reuters Recommended Reads

• Nov 3 - Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division

• Nov 3 - AdaptHealth posts Q3 loss due to goodwill impairment charge

• Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)